BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
6.14
+0.97 (18.76%)
At close: Dec 20, 2024, 4:00 PM
6.30
+0.16 (2.61%)
After-hours: Dec 20, 2024, 6:29 PM EST
BioAge Labs Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for BioAge Labs stock have an average target of 18, with a low estimate of 7.00 and a high estimate of 40. The average target predicts an increase of 193.16% from the current stock price of 6.14.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for BioAge Labs stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $45 → $7 | Strong Buy → Hold | Downgrades | $45 → $7 | +14.01% | Dec 9, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $42 → $7 | Strong Buy → Hold | Downgrades | $42 → $7 | +14.01% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +632.90% | Oct 21, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +551.47% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +584.04% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.48
from -38.17
EPS Next Year
-2.56
from -3.48
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.86 | -1.35 | -1.79 |
| Avg | -3.48 | -2.56 | -3.04 |
| Low | -4.32 | -3.01 | -4.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.